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Abstract
Background: Chronic heart failure (CHF) is a major public health problem characterised by progressive
deterioration with disabling symptoms and frequent hospital admissions. To influence hospitalisation rates it is
crucial to identify precipitating factors.
To characterise patients with CHF who seek an emergency department (ED) because of worsening symptoms and
signs and to explore the reasons why they are admitted to hospital.
Method: Patients (n = 2,648) seeking care for dyspnoea were identified at the ED, Sahlgrenska University Hospital/
Östra. Out of 2,648 patients, 1,127 had a previous diagnosis of CHF, and of these, 786 were included in the present
study with at least one sign and one symptom of worsening CHF.
Results: Although several of the patients wanted to go home after acute treatment in the ED, only 2% could be
sent home. These patients were enrolled in an interventional study, which evaluated the acute care at home
compared to the conventional, in hospital care. The remaining patients were admitted to hospital because of
serious condition, including pneumonia/respiratory disease, myocardial infarction, pulmonary oedema, anaemia, the
need to monitor cardiac rhythm, pathological blood chemistry and difficulties to communicate.
Conclusion: The vast majority of patients with worsening CHF seeking the ED required hospital care,
predominantly because of co-morbidities. Patients with CHF with symptomatic deterioration may be admitted to
hospital without additional emergency room investigations.
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Background
Chronic heart failure (CHF) is a major public health
problem and an increasing burden on health care provi-
ders and society [1]. It is commonly associated with
other chronic conditions e.g. coronary heart disease
(CHD), chronic obstructive pulmonary disease (COPD),
cardiacarrhythmia and diabetes [2]. CHF is often charac-
terised by progressive deterioration with disabling symp-
toms and frequent hospital admissions [3]. The annual
cost for treatment of CHF in Sweden is about 2% of the
Swedish health care budget, with the major part (75%)
constituting hospital care [4]. As described in the Swed-
ish national guidelines, them a j o r i t yo fp a t i e n t sw i t h
heart failure are managed by primary care physicians
[5]. Hospitalisation is common in these patients and in
a recent study it was shown that 31% of the patients
with heart failure (HF) in primary care were hospitalised
at least once during follow-up over a 2- year period [6].
Conversely, 65% of patients hospitalised for HF are fol-
l o w e do v e ra ne x t e n d e dp e r i o do ft i m ei np r i m a r yc a r e
[7]. Patients who develop acute HF or present with
severe symptoms are admitted directly to hospital for
treatment without first visiting a primary care physician
[5]. In addition, many of the patients controlled in the
hospital heart failure ambulatory department are sent to
the emergency department (ED) if their condition dete-
riorates. While the number of hospital beds in Sweden
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in 2005 during the past three decades, a reduction lar-
gely due to health care reforms, financial pressures (e.g.,
budget cuts) and rationalisation [8], a hospital readmis-
sion rate of 30-50% within 6 months after discharge has
been reported for patients with CHF [3]. Increases in
the prevalence of HF hospitalizations have also been
reported from other countries, e.g. Scotland [9], the
Netherlands [10], Spain [11], Singapore [12], Hong
Kong [13], and USA [14]. Overall, survival in CHF is
poor, where the 5-year survival rate in patients diag-
nosed in the late 1980s was about 40% [15]. However,
from the late 1980s and coinciding with the introduc-
tion of new treatments, such as angiotensin-converting
enzyme (ACE) inhibitors [16], beta-blockers [17], angio-
tensin receptor blockers (ARB) [18] and aldosterone
antagonists [19], long-term mortality for CHF has
decreased dramatically during the past two decades.
Even so, motality remains high for patients with HF
and continues to be a serious public health problem in
developing countries [20]. Shortness of breath, fatigue
and fluid retention are hallmarks of the CHF condition
[21]. As many as 32 symptoms have been described,
including dyspnoea, fatigue, pain, anxiety and loss of
appetite, depression and sleeping disorders [22]. We have
previously shown that dyspnoea is the most frequent
symptom in patients with deteriorating CHF that seek
emergency care [22]. There is no evidence that patients
with milder forms of CHF are hospitalised more often
today than in the past. Home-based care of patients with
worsening CHF after initial discharge from hospital may
reduce re-hospitalisation, mortality or both [23]. Many
patients treated for CHF experience worsening symptoms
long before seeking medical attention [22], which, if dis-
covered earlier, might be managed at home rather than
in hospital. Knowledge about factors related to re-hospi-
talisation in patients with CHF is important in designing
measures to prevent deterioration and avoid hospital
admission. A few studies that have investigated the pat-
tern of hospital readmission in patients with worsening
CHF identified abnormalities (e.g., respiratory infection,
arrhythmia, non adherence to prescribed treatment, cor-
onary ischaemia and inadequate preadmission treatment)
associated with clinical deterioration before admission
[24-26]. However, only one of these studies is from
northern Europe and that one is more than 10 years old
[24]. To influence hospitalisation rates of patients with
worsening CHF it is crucial to identify the precipitating
f a c t o r so ft h i sc o n d i t i o n .T h ep r e s e n ts t u d yh a dt w o
objectives. The first was to characterise patients who seek
the ED because of worsening CHF symptoms or signs.
The second objective was to investigate the reasons why
patients with worsening CHF require hospital care.
Methods
Between April 2004 and May 2006, patients seeking care
for dyspnoea were identified at the ED at Sahlgrenska
University Hospital/Östra, Göteborg, Sweden, a hospital
covering approximately 250 000 inhabitants and with
about 40 000 annual visits at the ED. The ED is divided
into an internal medicine unit and a unit devoted to
surgery care. Almost 18,000 visits per year are related to
medical conditions and a little more than half of these
patients (54%) are admitted to the department of medi-
cine (15% of all these admissions were related to HF).
The registration of patients and data collection was per-
formed by emergency and study physicians and study
nurses. All the patients visiting emergency department
seeking care for dyspnoea were identified and were
registered. From this population, patients with known
CHF were registered and details recorded regarding gen-
der, age, socio-economic status, heart rate, blood pres-
sure, symptoms and signs related to CHF. Patients with
CHF that were included because of their declining con-
dition had a prior diagnosis of CHF based on the Eur-
opean Society of Cardiology (ESC) Guidelines [21]. In
addition, these patients complained of dyspnoea and
required hospital care according to the attending physi-
cian. All these patients were invited to participate in a
study reported elsewhere [27] if they fulfilled all the
inclusion criteria (Table 1). In the present study, which
was retrospectively conducted, a number of demo-
graphic variables were registered and the reasons for
admission as well as echocardiographic findings were
retrieved from patient records. Approval was obtained
from The Regional Ethical Review Board (The Sahl-
grenska Academy, Ethics committee) and all participants
gave their written informed consent. The study con-
forms to the principles outlined in the Declaration of
Helsinki (international guidelines for medical research
on human subjects).
Statistical analysis
Statistical analyses were performed using SPSS version
14.0 for windows (SPSS Inc., Chicago, IL, USA).
Descriptive statistics were used to describe frequencies,
percentages, medians, means and standard deviations
(SD). Continuous variables were compared using Stu-
dent’s t test. A nominal significance level of 0.05 was
used (all tests were two-tailed).
Results
We screened 2,648 (51% women) patients, who sought
emergency department because of dyspnoea during the
study period (mean age 75 years; SD 14 years) (Figure
1). In the screened cohort of patients with dyspnoea, the
mean age for women was 77 years (SD 15 years) and for
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screened cohort of patients with dyspnoea, 1,127 (46%
women) were previously diagnosed with CHF (mean age
79 years; SD 11 years). The mean age of those patients
with CHF was for women 82 years (SD 12 years) years
and for men 76 years (SD 11 years) (p < 0.001). Of
those patients with previously diagnosed CHF, 786
(70%) were registered according to the criteria listed in
Table 1. These patients had the same age and gender
characteristics as the whole study group. Echocardiogra-
phy was performed in 38% of these patients (N = 295).
More than half (55%) of them had left ventricular systo-
lic dysfunction with an ejection fraction ≤45% (33%
women, mean age 78 years, SD10 years compared to
67% men, mean age 75 years, SD 10 years) (p = 0.09);
18% had heart failure with preserved ejection fraction
(HFPEF) (64% women, mean age 79 years, SD 8 years
compared to 36% men, mean age 76 years, SD 9 years)
(p = 0.20); and 16% had CHF that was due to valvular
disease (53% women, mean age 84 years, SD 9 years
compared to 47% men, mean age 77 years, SD 11 years)
(p = 0.003). 11% of the echocardiography examinations
were difficult to classify due to several potential causes
of CHF. Of the 786 CHF patients with deterioration,
only 2% (N = 15) could be sent home directly from the
ED after acute medical treatment while 4% (N = 31)
were included in a randomised trial assessing the feasi-
bility of home care in this context [27]. The rest of the
patients were admitted to hospital because of serious
conditions (e.g., pneumonia/respiratory disease, myocar-
dial infarction, pulmonary oedema, anaemia, need to
monitor cardiac rhythm, pathological blood chemistry
and communication difficulties resulting from dementia,
stroke and other medical conditions) (Table 2).
Discussion
The most important finding in our study was that, of
the 786 patients with worsening CHFseeking care in the
ED, only 2% could be sent home directly while the rest
were admitted to the hospital. In the patients with CHF,
who underwent echocardiography 55% presented with
systolic HF and 16% with valvular heart disease. The
number of patients with valvular heart disease in the
present study is higher than in previous studies [28,29].
Data on cause of CHF may vary substantially depending
on the type of study. For instance, where community
populations have been investigated [28] or populations
of admitted HF patients [29], about 10% of the CHF
patients had valvular disease. In clinical randomised
trials these patients are usually excluded and thus the
demographics between trials and practise differ in this
context. The high prevalence of valvular disease in our
Table 1 Criteria for inclusion in the registry of patients with a diagnosis of chronic heart failure (CHF) seeking
emergency care
Inclusion criteria Prior diagnosis of CHF with diastolic or systolic left ventricular dysfunction
Deterioration of CHF ≥ 3 days with symptoms of increasing dyspnoea, orthopnoea, weight gain ≥ 2
kg, debuting peripheral oedema or abdominal swelling
Signs of fluid retention or myocardial dysfunction, such as extended jugular vein, leg oedema,
tachypnoea, pulmonary crackles, ascites and third heart sound
At least one symptom and one sign should be present
New York Heart Association class II - IV
Systolic heart failure was defined as: Ejection fraction ≦ 45%.
Heart failure with preserved ejection
fraction was defined as:
Ejection fraction > 45% and signs of diastolic dysfunction:
One of the following criteria should be fulfilled:
- Posterior wall thickness + interventricular septum thickness/2 > 1.3 cm.
- Enlarged left atrium (female > 42 mm, male > 46 mm) in absence of atrial fibrillation.
   Screened       
patients with  
  known CHF
  (N = 1127)
CHF patients with deterioration   
    registered according to the  
           inclusion criteria 
       (The study population)
                   (N=786)
    
         Admitted to hospital
                  (N =740)
   Screened  
patients with  
   dyspnoea
  (N = 2648)
  Included in home care versus 
conventional hospital care study
                      (N =31)
     Sent home directly from ED    
                      (N=15) 
CHF patients with deterioration who 
did not fulfilled inclusion criteria
(N= 341)
Figure 1 Flow chart of patients and data availability.
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population (mean age 79 years, SD 11 years). Despite
patients’ desire to go home directly after acute treatment
from ED, they could not be sent home mainly because
of other comorbidities. Pneumonia and other respiratory
diseases were the most common reason for hospital
admission among patients with CHF in our study. Other
common reasons included the need for rhythm record-
ing and communication problems (such as dementia,
stroke and aphasia), which are in accordance with the
pattern found in studies of patients readmitted for wor-
sening CHF [24-26]. The major comorbidities reported
in the literature in patients with CHF are CHD, cerebro-
vascular disease, COPD, diabetes mellitus, renal failure,
and pneumonia [14]. Hence, even if the treatment of
CHF has developed markedly in the past years, the rea-
sons for admission of patients with worsening CHF
remain unchanged. Furthermore, the signs and symp-
toms are similar over the previous 20 years for patients
with worsening CHF who attend an ED [14]. The life-
prolonging therapies offered today might postpone, but
cannot significantly alter the presentation of worsening
C H FW eh a v ep r e v i o u s l ys h o w nt h a tt h ep r o g n o s t i c
importance of objective evidence of HF, e.g. left ventri-
cular ejection fraction (LVEF) is increased with simulta-
neous presence of symptoms [30,31]. These findings
suggest that self-assessed symptoms should serve as the
starting point when planning treatment and care of
these patients upon arrival at the ED. Symptoms are
important for the interpretation and understanding of
patients with CHF, as CHF is a syndrome characterized
by a cluster of symptoms. Symptoms are the foundation
for how we classify disease and symptoms can only be
experienced and described by the one who is affected, i.
e. patients. Therefore the patient’s own experience of ill-
ness must be taken seriously irrespective of type of care
[32]. Research indicates that home-based HF care after
initial discharge from hospital reduces rehospitalisation
and mortality [23]. Many patients treated for CHF
experience worsening symptoms long before seeking
medical attention [22], symptoms that might have been
p o s s i b l et om a n a g ea th o m er a t h e rt h a ni nh o s p i t a li f
discovered earlier. Considerable effort has been devoted
to educate patients and their relatives in identifying
symptoms and signs of worsening CHF but none of
these models seem to be sufficient as suggested by the
fact that when CHF patients seek the ED they need to
be admitted because of different complications. Our
findings indicate that communication about symptoms
between the health professionals and the patient is most
important. In this context person-centeredness (partner-
ship with and empowerment of the patient and family),
should be integrated in CHF management programs
[21]. Meanwhile, it seems that once the condition of
patients with CHD has deteriorated to the extent that
they must seek emergency care, hospital admission with
rapid stabilisation is the most effective approach to
improving care of patients with CHF mainly because of
comorbidities from other major diseases.
Limitations
The present study is small and single-centred and there-
fore the results cannot be generalised beyond the con-
text of the study. However, the pattern of patients in
our study corresponds to other studies in the same area
[24-26]. Another limitation is that the results from the
echocardiogram were available for only 38% of the eligi-
b l ep a t i e n t s .T h i sl o wf i g u r em a k e st h ef i n d i n g so fa
high percentage of valvular heart disease among the
patients who required hospital admission somewhat
uncertain.
Conclusion
In spite of our knowledge that the patients with CHF
delay in seeking care while worsening, they are in rapid
need of help once they decide to seek care at the ED.
Table 2 Reasons for hospital admission in patients with worsening CHF (The patients could be admitted for more than
one reason)
Reason for hospital admission Proportion Number
Pneumonia/respiratory disease 35.4% 278
Need to monitor cardiac rhythm 15.6% 123
Communication problem (such as dementia, stroke and aphasia) 22.3% 175
Pulmonary oedema 11.3% 89
Myocardial infarction 6.2% 49
Anaemia* 5.2% 41
Pathologic blood chemistry other than haemoglobin** 3.7% 29
Hypotension 2.1% 17
*S-Haemoglobinb < 100 g/L or a decrease of S-Haemoglobin > 20 g/L
** S-Creatinine > 250 μmol/L, S-Potassium > 5.5 mmol/L or < 3.4 mmol/L, S-Troponin T > 0.05 μg/L, Creatine kinase-MB > 5 μg/L, ASAT and ALAT > three times
above the normal value
Shafazand et al. BMC Research Notes 2012, 5:132
http://www.biomedcentral.com/1756-0500/5/132
Page 4 of 6Patients with severe chronic illness like CHF with symp-
tomatic deterioration should be attended with focus on
symptom relief and without additional emergency room
investigations before hospital admission. A person-cen-
tered approach of care will facilitate both the patient
and health care system. It is of utmost importance to
listen to the patient history on symptom deterioration
instead of solely focus on objective findings to provide
rapid and adequate care.
Acknowledgements
This work was supported by The Swedish Research Council, The Swedish
Association of Health Professionals, Göteborg and Southern Bohus County,
The Göteborg Medical Society, The Cardiology Research Foundation of the
Department of Medicine, Sahlgrenska University Hospital/Östra and The
Heart and Lung Foundation of Blekinge.
Author details
1Department of Emergency and Cardiovascular Medicine, Sahlgrenska
Academy, Sahlgrenska University Hospital/Östra, University of Gothenburg,
Gothenburg, Sweden.
2Institute of Health and Care Sciences, Sahlgrenska
Academy at University of Gothenburg, Gothenburg, Sweden. The Regional
Ethical Review Board: The Sahlgrenska Academy, Ethics committee.
Authors’ contributions
MS Participated in design of study, collected the data, performed statistical
analysis and drafted the manuscript, HP collected the data, IE participated in
design of study, KS participated in design of study, MS participated in
design of study and helped to draft of manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 31 August 2011 Accepted: 8 March 2012
Published: 8 March 2012
References
1. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A:
Decreasing one year mortality and hospitalisation rates for heart failure
in Sweden: data from the Swedish Hospital Discharge Registry 1988 to
2000. Eur Heart J 2004, 25:300-307.
2. Angermann CE: Comorbidities in heart failure: a key issue. Eur J Heart Fail
2009, 8:i5-i10.
3. McMurray J, Stewart S: Heart failure: epidemiology, aetiology and
prognosis of heart failure. Heart 2000, 83(5):596-602.
4. Rydén-Bergsten T, Andersson F: The health care costs of heart failure in
Sweden. J Intern Med 1999, 246:275-284.
5. Cline CM, Boman K, Holst M, Erhardt LR: Swedish society of cardiology
working group for heart failure. The management of heart failure in
Sweden. Eur J Heart Fail 2002, 4:373-376.
6. Malmberg I, Persson U: Primary health care costs in connection with
heart failure surveyed: increased use of ACE inhibitors would be
beneficial. Lakartidningen 2000, 97:2465-2470.
7. Persson H, Malmqvist K, Carlsson A, Rehnqvist N, Lundman T: More and
more persons suffer from heart failure. Better treatment and information
are necessary. Lakartidningen 1994, 91:3251-3254.
8. Bergström A: Sweden has the lowest number of beds in Europe (Sverige
har lägst antal vårdplatser i Europa). Lakartidningen 2007, 104:396-397.
9. McMurray J, McDonagh T, Morrison CE, Dargie HJ: Trends in
hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993,
14:1158-1162.
10. Reitsma JB, Mosterd A, de Craen AJ, et al: Increase in hospital admission
rates for heart failure in The Netherlands, 1980-1993. Heart 1996,
76:388-392.
11. Rodriguez-Artalejo F, Guallar-Castillon P, Banegas Banegas JR, Del Rey
Calero J: Trends in hospitalization and mortality for heart failure in Spain,
1980-1993. Eur Heart J 1997, 18:1771-1779.
12. Ng TP, Nitti M: Trends and ethnic differences in hospital admissions and
mortality for congestive heart failure in the elderly in Singapore, 1991 to
1998. Heart 2003, 89:865-870.
13. Hung YT, Cheung NT, Ip S, Fung H: Epidemiology of heart failure in Hong
Kong, 1997. Hong Kong Med J 2000, 6:159-162.
14. Oudejans I, Mosterd A, Bloemen JA, Valk MJ, Velzen Ev, Wielders JP,
Zuithoff NP, Rutten FH, Hoes AW: Clinical evaluation of geriatric
outpatients with suspected heart failure: value of symptoms, signs and
additional tests. Eur J Heart Fail 2011, 13:518-527.
15. Kannel WB, Ho K, Thom T: Changing epidemiological features of cardiac
failure. Br Heart J 1994, 72:3-9.
16. Garg R, Yusuf S: Overview of randomized trials of angiotensin converting
enzyme inhibitors on mortality and morbidity in patients with heart
failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995,
273:1450-1456.
17. McMurray J: Major beta blocker mortality trials in chronic heart failure: a
critical review. Heart 1999, 82:14-22.
18. Pfeffer M, Swedberg K, Granger C, Held P, McMurray J, Michelsen E,
Olofsson B, Ostergren J, Yusuf S, Pocock S, CHARM Investigators and
Committees: Effects of candesartan on mortality and morbidity in
patients with chronic heart failure: the CHARM-Overall programme.
Lancet 2003, 362:759-766.
19. Pitt B, Rajagopalan S: Aldosterone receptor antagonists for heart failure:
current status, future indications. Cleve Clin J Med 2006, 73(257-
60):264-268.
20. Shafazand M, Schaufelberger M, Lappas G, Swedberg K, Rosengren A:
Survival trends in men and women with heart failure of ischaemic and
non-ischaemic origin: data for the period 1987-2003 from the Swedish
Hospital Discharge Registry. Eur Heart J 2009, 30:671-678.
21. Dickstein K, Cohen-Solal A, Filippatos G, et al: ESC guidelines. Task force
for diagnosis and treatment of acute and chronic heart failure 2008 of
european society of cardiology. Eur Heart J 2008, 29(19):2388-2442.
22. Patel H, Shafazand M, Schaufelberger M, Ekman I: Reasons for seeking
acute care in chronic heart failure. Eur J Heart Fail 2007, 9:702-708.
23. Stewart S, Horowitz JD: Home based intervention in congestive heart
failure: long term implications on readmission and survival. Circulation
2002, 105:2861-2866.
24. Ekman I, Andersson B, Ehnfors M, Matejka G, Persson B, Fagerberg B:
Feasibility of a nurse-monitored outpatient-care programme for elderly
patients with moderate-to severe, chronic heart failure. Eur Heart J 1998,
19:1254-1260.
25. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M,
Greenberg BH, O’Connor CM, Pieper K, Sun JL, Yancy CW, Young JB:
OPTIMIZE-HF Investigators and Hospitals. Factors identified as
precipitating hospital admissions for heart failure and clinical outcomes:
findings from OPTIMIZE-HF. Arch Intern Med 2008, 28:847-854.
26. Tsuyuki RT, McKelvie RS, Arnold JM, Avezum A Jr, Barretto AC, Carvalho AC,
Isaac DL, Kitching AD, Piegas LS, Teo KK, Yusuf S: Acute precipitants of
congestive heart failure exacerbations. Arch Intern Med 2001,
161:2337-2342.
27. Patel H, Shafazand M, Ekman I, Höjgård S, Swedberg K, Schaufelberger M:
Home care as an option in worsening chronic heart failure-a pilot study
to evaluate feasibility, quality adjusted life years and cost-effectiveness.
Eur J Heart Fail 2008, 10:675-681.
28. Philbin EF, Rocco TA, Lindenmuth NW, Ulrich K, Jenkins PL: Systolic versus
diastolic heart failure in community practice: clinical features, outcomes,
and use of angiotensin-converting enzyme inhibitors. Am J Med 2000,
109:605-613.
29. Khand Au, Gemmell I, Rankin AC, Cleland GF: Clinical events leading to
the progression of heart failure: insights from a national database of
hospital discharges. Eur Heart J 2001, 22:153-164.
30. Ekman I, Kjörk E, Andersson B: Self-assessed symptoms in chronic heart
failure-Important information for clinical management. Eur J Heart Fail
2007, 9:424-428.
31. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-
Wilson PA: Self assessed symptoms. Symptoms in patients with heart
Shafazand et al. BMC Research Notes 2012, 5:132
http://www.biomedcentral.com/1756-0500/5/132
Page 5 of 6failure are prognostic predictors: insights from COMET. J Card Fail 2005,
11:288-292.
32. Ekman I, Cleland JGF: Exploring symptoms in chronic heart failure.
Editorial. Eur J Heart Fail 2005, 7:699-703.
doi:10.1186/1756-0500-5-132
Cite this article as: Shafazand et al.: Patients with worsening chronic
heart failure who present to a hospital emergency department require
hospital care. BMC Research Notes 2012 5:132.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Shafazand et al. BMC Research Notes 2012, 5:132
http://www.biomedcentral.com/1756-0500/5/132
Page 6 of 6